Stock screenerAll disclosures →
EDGAR →
VTRS
Conviction 80HealthcareScan · Mon, Jul 20, 2026VTRS$17.01-1.62%
ResistanceSupportVol 14Insider sellCongress buyCongress sellVol MA14 9.24M
Apr 20May 6May 26Jun 11Jul 1Jul 20
Price17.01
Change-1.62%
Gap+0.75%
Rel volume0.69×
Avg volume9.5M
Avg $ vol155.82M
SMA 2016.42
SMA 5016.37
SMA 20013.61
Price vs 50+3.91%
Price vs 200+24.98%
MA stackbullish
50/200 cross—
Supertrendup · 16.00
RSI (14)59
MACD hist0.07
MACD crossbull · 3d
Stoch %K / %D65 / 80
ADX (14)14
+DI / −DI33 / 22
RSI divergence—
MACD divergence—
ATR %+2.85%
ADR %2.75%
52w high17.39
52w low8.74
From 52w high-2.19%
Above 52w low+94.62%
New 52w highNo
SqueezeOff
Bollinger width12.06%
%B0.80
Donchian pos74.62%
Donchian high17.67
Donchian low15.07
AVWAP (52w high)17.30
vs AVWAP high-1.66%
AVWAP (52w low)13.19
vs AVWAP low+28.99%
OBV trendUp
Chaikin MF (20)0.04
Today vs 20d0.69×
Avg vol (14d)9.24M
Avg vol (20d)9.5M
Avg $ vol (20d)155.82M
Market cap19.81B
RS 3m (vs SPY)+17.48%
RS 6m (vs SPY)+23.82%
RS line new highNo
Trend template8/8
Technical rank87.4
1 week+3.78%
1 month+8.14%
3 months+15.87%
6 months+32.48%
1 year+83.50%
YTD+36.52%
P/E—
P/B-98.55
P/S1.39
P/FCF10.23
EPS-3.00
Div yield—
ROE0.00%
ROA0.00%
Debt/Eq-71.37
Current1.60
EV/EBITDA239.27
Gross margin35.18%
Net margin0.00%
Rev growth-3.01%
EPS growth—
Price target17.00
Target upside-0.06%
Analyst ratingHold
Institutional98.71%
Ent. value32.35B
Revenue3.51B
Net income-169M
Gross profit1.16B
Free cash flow1.94B
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out1.16B
Employees30K
ListedFri, Feb 23, 1973
Free float1.16B
Float %99.7%
Short interest48.02M
Days to cover4.4d
Short volume60.2%
Squeeze score44 / 100
Next earningsThu, Aug 6, 2026 · pre-mkt (17d)
EPS forecast$0.62 · 4 est
Last EPS vs est$0.59 vs $0.52
Last surprise+13.5% beat
Setup gradeA
Conviction80 / 100
Pattern quality—
Tech rank87.4 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance16.96
Support15.22
Days since event—
Candle confirm—
News sentiment—
Financials as of Sun, Sep 27, 2020 · quarterly.
Congress activity
Disclosed STOCK Act trades in VTRS · 3 recent
Insider activity
SEC Form 4 transactions in VTRS · 2 buys · 5 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Campbell Paul See Remarks · Common Stock · 2026-06-25 | Sell | 50.08K | $810K | 2026-06-25 | 2026-06-26 |
Le Goff Corinne Chief Commercial Officer · Common Stock · 2026-04-15 | Tax | 17.45K | $242K | 2026-04-15 | 2026-04-16 |
Le Goff Corinne Chief Commercial Officer · Common Stock · 2026-04-15 | Exercise | 39.34K | $0 | 2026-04-15 | 2026-04-16 |
Le Goff Corinne Chief Commercial Officer · Common Stock · 2026-04-15 | Exercise | 3.64K | $0 | 2026-04-15 | 2026-04-16 |
Le Goff Corinne Chief Commercial Officer · Dividend Equivalent Units · 2026-04-15 | Exercise | 3.64K | $0 | 2026-04-15 | 2026-04-16 |
Le Goff Corinne Chief Commercial Officer · Common Stock · 2026-04-15 | Tax | 1.62K | $22K | 2026-04-15 | 2026-04-16 |
Le Goff Corinne Chief Commercial Officer · Restricted Stock Units · 2026-04-15 | Exercise | 39.34K | $0 | 2026-04-15 | 2026-04-16 |
SEC filings
EDGAR filings in VTRS · 7 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.